![](https://www.pdfsearch.io/img/5a983f00bbfe583a44cfb1c91bed3478.jpg) Date: 2016-07-29 19:00:51
| | Intersect ENT Announces FDA Submission of NOVA Bioabsorbable Steroid Releasing Implant for Patients with Chronic Sinus Disease MENLO PARK, Calif.—Aug. 1, 2016—Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated toAdd to Reading ListSource URL: propelopens.comDownload Document from Source Website File Size: 29,02 KBShare Document on Facebook
|